Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial.

ABSTRACT: With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is often not addressed in the context of HIV care, and few individuals are offered cessation treatment. Optimizing tobacco treatment delivery for PWH may increase engagement with evidence-based treatments and successful quit attempts. The current study is a type 1 hybrid effectiveness-implementation trial to evaluate the impact of a proactive, opt-out tobacco treatment intervention on cessation outcomes and advance understanding of key barriers and facilitators of implementation processes. A total of 230 PWH who smoke will be recruited from an infectious diseases clinic at an academic medical center and will

SUBMITTER: Sanford BT 

PROVIDER: S-EPMC9636678 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature